167 related articles for article (PubMed ID: 32804187)
1. Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19.
Chua KP; Conti RM
JAMA Intern Med; 2020 Oct; 180(10):1273-1274. PubMed ID: 32804187
[No Abstract] [Full Text] [Related]
2. A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir.
Liang C; Tian L; Liu Y; Hui N; Qiao G; Li H; Shi Z; Tang Y; Zhang D; Xie X; Zhao X
Eur J Med Chem; 2020 Sep; 201():112527. PubMed ID: 32563812
[TBL] [Abstract][Full Text] [Related]
3. Drug repositioning is an alternative for the treatment of coronavirus COVID-19.
Serafin MB; Bottega A; Foletto VS; da Rosa TF; Hörner A; Hörner R
Int J Antimicrob Agents; 2020 Jun; 55(6):105969. PubMed ID: 32278811
[TBL] [Abstract][Full Text] [Related]
4. Antiviral treatment for COVID-19: the evidence supporting remdesivir.
Richardson C; Bhagani S; Pollara G
Clin Med (Lond); 2020 Nov; 20(6):e215-e217. PubMed ID: 32863273
[TBL] [Abstract][Full Text] [Related]
5. Compassionate Use of Remdesivir for Patients with Severe Covid-19.
Grein J; Ohmagari N; Shin D; Diaz G; Asperges E; Castagna A; Feldt T; Green G; Green ML; Lescure FX; Nicastri E; Oda R; Yo K; Quiros-Roldan E; Studemeister A; Redinski J; Ahmed S; Bernett J; Chelliah D; Chen D; Chihara S; Cohen SH; Cunningham J; D'Arminio Monforte A; Ismail S; Kato H; Lapadula G; L'Her E; Maeno T; Majumder S; Massari M; Mora-Rillo M; Mutoh Y; Nguyen D; Verweij E; Zoufaly A; Osinusi AO; DeZure A; Zhao Y; Zhong L; Chokkalingam A; Elboudwarej E; Telep L; Timbs L; Henne I; Sellers S; Cao H; Tan SK; Winterbourne L; Desai P; Mera R; Gaggar A; Myers RP; Brainard DM; Childs R; Flanigan T
N Engl J Med; 2020 Jun; 382(24):2327-2336. PubMed ID: 32275812
[TBL] [Abstract][Full Text] [Related]
6. Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies.
Singh AK; Singh A; Singh R; Misra A
Diabetes Metab Syndr; 2020; 14(4):641-648. PubMed ID: 32428865
[TBL] [Abstract][Full Text] [Related]
7. Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019.
Igbinosa I; Miller S; Bianco K; Nelson J; Kappagoda S; Blackburn BG; Grant P; Subramanian A; Lyell DJ; El-Sayed YY; Aziz N
Am J Obstet Gynecol; 2020 Nov; 223(5):768-770. PubMed ID: 32771381
[No Abstract] [Full Text] [Related]
8. Case report study of the first five COVID-19 patients treated with remdesivir in France.
Dubert M; Visseaux B; Isernia V; Bouadma L; Deconinck L; Patrier J; Wicky PH; Le Pluart D; Kramer L; Rioux C; Le Hingrat Q; Houhou-Fidouh N; Yazdanpanah Y; Ghosn J; Lescure FX
Int J Infect Dis; 2020 Sep; 98():290-293. PubMed ID: 32619764
[TBL] [Abstract][Full Text] [Related]
9. Is hydroxychloroquine beneficial for COVID-19 patients?
Li X; Wang Y; Agostinis P; Rabson A; Melino G; Carafoli E; Shi Y; Sun E
Cell Death Dis; 2020 Jul; 11(7):512. PubMed ID: 32641681
[TBL] [Abstract][Full Text] [Related]
10. Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy.
Helleberg M; Niemann CU; Moestrup KS; Kirk O; Lebech AM; Lane C; Lundgren J
J Infect Dis; 2020 Sep; 222(7):1103-1107. PubMed ID: 32702095
[TBL] [Abstract][Full Text] [Related]
11. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence.
Cao YC; Deng QX; Dai SX
Travel Med Infect Dis; 2020; 35():101647. PubMed ID: 32247927
[TBL] [Abstract][Full Text] [Related]
12. Remdesivir for the Treatment of Covid-19 - Final Report.
Beigel JH; Tomashek KM; Dodd LE; Mehta AK; Zingman BS; Kalil AC; Hohmann E; Chu HY; Luetkemeyer A; Kline S; Lopez de Castilla D; Finberg RW; Dierberg K; Tapson V; Hsieh L; Patterson TF; Paredes R; Sweeney DA; Short WR; Touloumi G; Lye DC; Ohmagari N; Oh MD; Ruiz-Palacios GM; Benfield T; Fätkenheuer G; Kortepeter MG; Atmar RL; Creech CB; Lundgren J; Babiker AG; Pett S; Neaton JD; Burgess TH; Bonnett T; Green M; Makowski M; Osinusi A; Nayak S; Lane HC;
N Engl J Med; 2020 Nov; 383(19):1813-1826. PubMed ID: 32445440
[TBL] [Abstract][Full Text] [Related]
13. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.
Antinori S; Cossu MV; Ridolfo AL; Rech R; Bonazzetti C; Pagani G; Gubertini G; Coen M; Magni C; Castelli A; Borghi B; Colombo R; Giorgi R; Angeli E; Mileto D; Milazzo L; Vimercati S; Pellicciotta M; Corbellino M; Torre A; Rusconi S; Oreni L; Gismondo MR; Giacomelli A; Meroni L; Rizzardini G; Galli M
Pharmacol Res; 2020 Aug; 158():104899. PubMed ID: 32407959
[TBL] [Abstract][Full Text] [Related]
14. Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials.
Abrams-Downey A; Saabiye J; Vidaurrazaga M
Eur Urol Focus; 2020 Sep; 6(5):1028-1031. PubMed ID: 32563675
[No Abstract] [Full Text] [Related]
15. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.
Williamson BN; Feldmann F; Schwarz B; Meade-White K; Porter DP; Schulz J; van Doremalen N; Leighton I; Yinda CK; Pérez-Pérez L; Okumura A; Lovaglio J; Hanley PW; Saturday G; Bosio CM; Anzick S; Barbian K; Cihlar T; Martens C; Scott DP; Munster VJ; de Wit E
Nature; 2020 Sep; 585(7824):273-276. PubMed ID: 32516797
[TBL] [Abstract][Full Text] [Related]
16. Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir.
Jockusch S; Tao C; Li X; Chien M; Kumar S; Morozova I; Kalachikov S; Russo JJ; Ju J
Sci Rep; 2020 Oct; 10(1):16577. PubMed ID: 33024223
[TBL] [Abstract][Full Text] [Related]
17. Using "old" medications to fight new COVID-19: Re-purposing with a purpose.
Wang Y; Foo R; Thum T
J Mol Cell Cardiol; 2020 Sep; 146():41-42. PubMed ID: 32687852
[No Abstract] [Full Text] [Related]
18. COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons.
Nile SH; Nile A; Qiu J; Li L; Jia X; Kai G
Cytokine Growth Factor Rev; 2020 Jun; 53():66-70. PubMed ID: 32418715
[TBL] [Abstract][Full Text] [Related]
19. Potential therapeutic agents against COVID-19: What we know so far.
Lu CC; Chen MY; Lee WS; Chang YL
J Chin Med Assoc; 2020 Jun; 83(6):534-536. PubMed ID: 32243270
[TBL] [Abstract][Full Text] [Related]
20. Remdesivir: Review of Pharmacology, Pre-clinical Data, and Emerging Clinical Experience for COVID-19.
Jorgensen SCJ; Kebriaei R; Dresser LD
Pharmacotherapy; 2020 Jul; 40(7):659-671. PubMed ID: 32446287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
